PRENW Prenetics Global Ltd
Price Chart
Executive Summary
Prenetics Global Ltd announced a multi-year global partnership with Jay Shetty, naming him the first non-sport global ambassador for its IM8 health brand and granting him shareholder status. The filing also notes that Prenetics raised its full-year 2026 IM8 revenue guidance to $190-210 million following preliminary Q1 2026 IM8 revenue of $33.8 million, representing nearly 6x year-over-year growth, with May 2026 monthly revenue tracking at approximately $15.5 million implying ~$186 million annualized recurring revenue.
Actionable Insight
The Jay Shetty ambassador deal broadens IM8's reach into wellness/mindfulness beyond sports, and his equity stake aligns him with long-term value creation. The nearly 6x YoY Q1 revenue growth and raised guidance strongly reinforce the IM8 growth trajectory. Watch for upcoming quarterly filings to confirm sustained revenue momentum and any margin expansion; the brand's international penetration (60%+ non-US revenue) is a key differentiation to monitor.
Key Facts
- Multi-year partnership with Jay Shetty as IM8 Global Ambassador and shareholder in Prenetics.
- Shetty brings over 70 million followers and 700 million monthly views across platforms.
- Preliminary Q1 2026 IM8 revenue of $33.8 million, nearly 6x year-over-year growth.
- Full-year 2026 IM8 revenue guidance raised to $190 million to $210 million.
- May 2026 monthly revenue tracking at ~$15.5 million, implying ~$186 million annualized recurring revenue.
- IM8 delivers approximately 150,000 servings daily across 43 countries.
- Over 60% of IM8 revenue is generated outside the United States.
Financial Impact
Implied annualized revenue run rate of ~$186M per May 2026 monthly data, with FY2026 guidance raised to $190M-210M. Q1 2026 IM8 revenue was $33.8M vs near-zero revenue 17 months ago.
Risk Factors
- Premium supplement category is competitive; brand momentum may decelerate.
- Guidance is forward-looking and subject to execution risk; any slowdown in subscriber/repeat purchase rates could pressure the stock.
- Dependence on high-profile celebrity endorsers creates key-person and reputation risk.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-036726 |
| Document: im8_jayxshettyxambassadorx.htm | 0001628280-26-036726 |
| Document: 0001628280-26-036726-index-headers.html | 0001628280-26-036726 |
| Document: 0001628280-26-036726-index.html | 0001628280-26-036726 |
| Document: 0001628280-26-036726.txt | 0001628280-26-036726 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 10, 2026
3d ago
|
6-K
| $0.0195 awaiting T+1 | awaiting T+1 | — | $0.0195 (+0.00%) |
|
Jun 4, 2026
9d ago
|
6-K
| $0.0195 $0.0195 | · 0.00% | ▲ +2.60% | $0.0195 (+0.00%) |
|
May 20, 2026
24d ago
|
6-K
| $0.0195 $0.0195 | · 0.00% | ▼ −0.19% | $0.0195 (+0.00%) |
|
May 14, 2026
4w ago
|
6-K
| $0.0195 $0.0195 | · 0.00% | ▲ +1.23% | $0.0195 (+0.00%) |
|
May 14, 2026
4w ago
|
6-K
| $0.0195 $0.0195 | · 0.00% | ▲ +1.23% | $0.0195 (+0.00%) |
|
May 4, 2026
5w ago
|
6-K
| $0.0195 $0.0195 | · 0.00% | ▼ −0.80% | $0.0195 (+0.00%) |
|
Apr 2, 2026
10w ago
|
6-K
| $0.0195 $0.0195 | · 0.00% | ▼ −0.48% | $0.0195 (+0.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access